P1.01-106 Pembrolizumab Randomized, Phase 1 Study in Chinese Patients with Advanced NSCLC: KEYNOTE-032
JOURNAL OF THORACIC ONCOLOGY(2018)
关键词
pembrolizumab,NSCLC,biomarker
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF THORACIC ONCOLOGY(2018)